| Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.) (NCT02088203) | Pennington Biomedical Research Center | 2014-02-01 |
| DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV) (NCT02063360) | ViiV Healthcare | 2014-02-01 |
| Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor (NCT01985256) | Tocagen Inc. | 2014-02-01 |
| Effects of Transcranial Direct Current Stimulation Associated With Physical Exercise: a Metaplasticity Study (NCT02263092) | Universidade Federal de Pernambuco | 2014-02-01 |
| Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma) (NCT02550756) | Centrexion Therapeutics | 2014-02-01 |
| A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011) (NCT02049281) | Endocyte | 2014-02-01 |
| Mesenchymal Stromal Cells for Degenerative Meniscus Injury (NCT02033525) | Banc de Sang i Teixits | 2014-01-31 |
| A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors (NCT02045095) | Millennium Pharmaceuticals, Inc. | 2014-01-31 |
| CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation (NCT01995708) | Memorial Sloan Kettering Cancer Center | 2014-01-31 |
| Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer (NCT01784640) | Jonsson Comprehensive Cancer Center | 2014-01-31 |
| Pharmacokinetics and Safety in Healthy Volunteers (NCT02045979) | Boehringer Ingelheim | 2014-01-31 |
| A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects (NCT02006537) | GlaxoSmithKline | 2014-01-31 |
| An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in ISIS 396443-CS2 (NCT01703988) or ISIS 396443-CS10 (NCT01780246) (NCT02052791) | Biogen | 2014-01-31 |
| STP206 for the Prevention of Necrotizing Enterocolitis (NEC) (NCT01954017) | Leadiant Biosciences, Inc. | 2014-01-30 |
| ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia (NCT02029443) | Acerta Pharma BV | 2014-01-30 |
| Fasting Comparative Bioavailability Study of 2 Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition (NCT05125588) | Joint Stock Company "Farmak" | 2014-01-29 |
| Immunomodulation by Zinc Supplementation in Children With Pneumonia (NCT03690583) | Universidad Nacional Autonoma de Mexico | 2014-01-29 |
| Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) (NCT02003573) | Boehringer Ingelheim | 2014-01-29 |
| A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer (NCT02045953) | GlaxoSmithKline | 2014-01-29 |
| Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy (NCT02121639) | University Hospital Southampton NHS Foundation Trust | 2014-01-29 |
| Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection (NCT01780831) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-28 |
| Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R (NCT02045368) | IGF Oncology, LLC | 2014-01-28 |
| Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain (NCT04737278) | Mitosynergy LLC | 2014-01-28 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects (NCT02058407) | GlaxoSmithKline | 2014-01-28 |
| Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004) (NCT02037984) | Merck Sharp & Dohme LLC | 2014-01-28 |
| Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects (NCT02045849) | GlaxoSmithKline | 2014-01-28 |
| Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome (NCT02052908) | National Cancer Institute (NCI) | 2014-01-27 |
| Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects. (NCT02080455) | Aegerion Pharmaceuticals, Inc. | 2014-01-27 |
| A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome (NCT01981525) | National Cancer Institute (NCI) | 2014-01-27 |
| Immunization Via Mosquito Bite With Radiation-attenuated Sporozoites (NCT01994525) | U.S. Army Medical Research and Development Command | 2014-01-24 |
| NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma (NCT01810016) | Ludwig Institute for Cancer Research | 2014-01-24 |
| A Validation and Dosimetry Study of GSK2634673F PET Ligand (NCT02052297) | GlaxoSmithKline | 2014-01-24 |
| Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1) (NCT01976169) | University of Texas Southwestern Medical Center | 2014-01-24 |
| An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations (NCT02192697) | Astellas Pharma Inc | 2014-01-23 |
| S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer (NCT01959139) | SWOG Cancer Research Network | 2014-01-23 |
| Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT02044796) | Fred Hutchinson Cancer Center | 2014-01-23 |
| Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers (NCT02033668) | GlaxoSmithKline | 2014-01-22 |
| A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine. (NCT02052726) | Pfizer | 2014-01-22 |
| A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection (NCT01715909) | Hoffmann-La Roche | 2014-01-22 |
| Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers (NCT02037165) | Boehringer Ingelheim | 2014-01-21 |
| Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial (NCT01896388) | Chiba University | 2014-01-21 |
| A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients (NCT02035605) | Sanofi | 2014-01-20 |
| A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults (NCT05319899) | Alexion Pharmaceuticals, Inc. | 2014-01-20 |
| Multichannel tDCS to Reduce Hypertonia in Patients With Prolonged DOC (NCT03797573) | University of Liege | 2014-01-20 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses (NCT02045940) | GlaxoSmithKline | 2014-01-20 |
| BP-C1 in Metastatic Breast Cancer Patients (NCT01861509) | Meabco A/S | 2014-01-19 |
| Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment (NCT01765244) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2014-01-17 |
| Study to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effect Study (NCT02049528) | Celgene | 2014-01-16 |
| N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan (NCT02030964) | New Approaches to Neuroblastoma Therapy Consortium | 2014-01-16 |
| Extension Study of PRX-102 for up to 60 Months (NCT01981720) | Protalix | 2014-01-16 |
| Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer (NCT01824901) | ECOG-ACRIN Cancer Research Group | 2014-01-15 |
| A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors (NCT02099058) | AbbVie | 2014-01-15 |
| A Methodology Study to Assess Muscle Damage After Eccentric Exercise (NCT02014662) | GlaxoSmithKline | 2014-01-14 |
| TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03) (NCT02043847) | University of Illinois at Chicago | 2014-01-14 |
| Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression (NCT02201303) | GlaxoSmithKline | 2014-01-13 |
| A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL) (NCT01671904) | Genentech, Inc. | 2014-01-13 |
| The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors (NCT02031731) | Hoffmann-La Roche | 2014-01-13 |
| Medication Enhanced Rapid Therapy (NCT02099825) | Washington University School of Medicine | 2014-01-13 |
| A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes (NCT02035371) | Novo Nordisk A/S | 2014-01-13 |
| Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen (NCT04080297) | Que Oncology | 2014-01-10 |
| Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected (NCT01632891) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-01-10 |
| Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma (NCT02043860) | University of Illinois at Chicago | 2014-01-10 |
| Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002 (NCT01984047) | GlaxoSmithKline | 2014-01-10 |
| Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma (NCT01870726) | Novartis Pharmaceuticals | 2014-01-09 |
| Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2) (NCT01970176) | Mayo Clinic | 2014-01-09 |
| A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations (NCT01970865) | Pfizer | 2014-01-08 |
| Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma (NCT02010606) | Cedars-Sinai Medical Center | 2014-01-08 |
| Omalizumab for Lupus (NCT01716312) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2014-01-08 |
| Phase I Study of Safety and Immunogenicity of ADU-623 (NCT01967758) | Providence Health & Services | 2014-01-08 |
| Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men (NCT02236988) | Amgen | 2014-01-07 |
| Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma (NCT02032810) | H. Lee Moffitt Cancer Center and Research Institute | 2014-01-07 |
| Dendritic Cell Vaccine for Children and Adults With Sarcoma (NCT01803152) | Macarena De La Fuente, MD | 2014-01-06 |
| Doxycycline in the Treatment of Aggressive Periodontitis (NCT03727620) | Mohammed V Souissi University | 2014-01-06 |
| Ublituximab + Ibrutinib in Select B-cell Malignancies (NCT02013128) | TG Therapeutics, Inc. | 2014-01-06 |
| Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma (NCT01988493) | Merck KGaA, Darmstadt, Germany | 2014-01-06 |
| A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy (NCT02111824) | The Methodist Hospital Research Institute | 2014-01-05 |
| Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus (NCT01941056) | City of Hope Medical Center | 2014-01-05 |
| Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression? (NCT02049385) | National Institute of Mental Health (NIMH) | 2014-01-03 |
| A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects (NCT02037282) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-03 |
| A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101) (NCT02028065) | Merck Sharp & Dohme LLC | 2014-01-03 |
| In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy (NCT01976585) | Joshua Brody | 2014-01-03 |
| A Novel Compound for Alcoholism Treatment (NCT02039349) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2014-01-03 |
| Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia (NCT02041910) | Hesham Saeed Elshaer | 2014-01-01 |
| Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC) (NCT02152007) | TransDerm, Inc. | 2014-01-01 |
| To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects (NCT01818869) | AstraZeneca | 2014-01-01 |
| Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer (NCT01980277) | Institut Paoli-Calmettes | 2014-01-01 |
| A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone (NCT02019329) | Hoffmann-La Roche | 2014-01-01 |
| A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma (NCT02035657) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-01-01 |
| Study to Investigate Relative Bioavailability of up to Five Different Formulations of AZD5069 (NCT01989520) | AstraZeneca | 2014-01-01 |
| Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis (NCT01807286) | M.D. Anderson Cancer Center | 2014-01-01 |
| Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788 (NCT01999725) | Enanta Pharmaceuticals, Inc | 2014-01-01 |
| Electroacupuncture for Diminished Ovarian Reserve (NCT02229604) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2014-01-01 |
| A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil (NCT02055703) | Eisai Inc. | 2014-01-01 |
| Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens (NCT01854099) | University of Florida | 2014-01-01 |
| Bioavailability of ABT-450 and ABT-267 With Ritonavir (NCT02052362) | AbbVie | 2014-01-01 |
| Effect of Apelin on Insulin Sensitivity: Proof of Concept in Healthy Volunteers (NCT02033473) | University Hospital, Toulouse | 2014-01-01 |
| Single-port Versus Conventional Laparoscopic Colorectal Surgery (NCT01626963) | North Tees and Hartlepool NHS Foundation Trust | 2014-01-01 |
| Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL). (NCT01978782) | Radboud University Medical Center | 2014-01-01 |
| Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer (NCT02069145) | OncoMed Pharmaceuticals, Inc. | 2014-01-01 |
| Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia (NCT02047149) | University of Massachusetts, Worcester | 2014-01-01 |